ABT—One loud and clear result from today’s HCV abstract—no matter what else happens in the trial in question—is that the AbbVie spinoff is much more than just Humira.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.